Navigation Links
Epeius Biotechnologies Leads With Keynote Address on the Advent of Pathotropic Medicine for Cancer at the Global Pharma R&D Summit Conference in Boston MA
Date:10/18/2007

SAN MARINO, Calif., Oct. 18 /PRNewswire/ -- Epeius Biotechnologies Corporation today announced that Dr. Frederick L. Hall, President and CEO of Epeius Biotechnologies Inc., has accepted an invitation to give the lead keynote address on "The Advent of Pathotropic Medicine for Cancer" at the Global Pharma R&D Summit 2007 to be held in Boston MA. On October 22, 2007 at 8:00 a.m., Dr. Hall will present the scientific principles, the clinical validation, and global development status of the company's innovative pathotropic (disease-seeking) -- targeting technology embodied in its lead product, Rexin-G, the first pathotropically targeted genetic medicine developed for the treatment of advanced-stage and metastatic cancer.

(LOGO 72dpi: Send2Press.com/mediaboom/logo-epeius_72dpi.jpg)

The Global Pharma R&D Summit 2007 (http://www.globalpharmasummit.com), which will be held at the Boston Marriott Hotel, Newton MA 02466 USA, on October 22-23, 2007, showcases cutting-edge biotechnology and pharmaceutical companies that are developing superior technologies and products in healthcare and healthcare related areas, and offers a forum to meet with suppliers, service providers, opinion leaders, and representatives from other leading pharmaceutical and biotechnology companies worldwide. The Keynote Address provides an opportunity for Epeius to update the industry in regard to its recent clinical developments and global partnering initiatives to expedite the international development of Rexin-G, which is currently in clinical trials in Europe, Japan, and ASEAN member countries, as well as the United States.

The focus on Epeius Biotechnologies during National Breast Cancer Awareness Month, is apropos-for the company has just opened an Advanced Phase I/II trial for chemo-resistant breast cancer in San Marino and Santa Monica California. Rexin-G, has received Orphan Drug Status from the FDA based on unp
'/>"/>

SOURCE Epeius Biotechnologies
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. The development of a CXCR2 chemokine receptorbinding assay using the LEADseeker Multimodality Imaging System
2. Performance of the AMARA HitHunter Chemiluminescence Kinase Assay with the LEADseeker Multimodality Imaging System
3. The development of a melanocortin MC4 receptor binding assay using the LEADseeker Multimodality Imaging System
4. The development of a melanocortin MC5 receptor binding assay using the LEADseeker Multimodality Imaging System
5. The development of a calcitonin-gene related peptide (CGRP) receptor-binding assay using the LEADseeker Multimodality Imaging System
6. Development of a histamine H1 receptor binding assay using the LEADseeker Multimodality Imaging System
7. Performance of fluorescent dyes with LEADseeker Multimodality Imaging System
8. Use of the HitHunter EFC Chemiluminescent Detection Kits with LEADseeker Multimodality Imaging System
9. Use of BRET2 luminescence cell-based assays with LEADseeker Multimodality Imaging System
10. Development of an NK2 neuropeptide receptor binding assay using LEADseeker Multimodality Imaging System
11. The development of a somatostatin sst4 receptor-binding assay using the LEADseeker Multimodality Imaging System
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/21/2015)... SURPRISE, ARIZ. (PRWEB) May 21, 2015 ... E. Webb Medical Center (BDWMC), Sun Health Foundation funded ... medical center’s new inpatient pharmacy with the most up-to-date ... to open June 2. The pharmacy's 45 staff members ... much larger 4,895-square-foot space in the coming days. ...
(Date:5/20/2015)... Calif. , May 20, 2015 ... today presented preliminary data demonstrating the ability of ... pulmonary fibrosis (IPF) from other interstitial lung diseases ... suggest the classifier,s potential to help thousands of ... resolve ambiguity in IPF diagnosis – a frequent ...
(Date:5/20/2015)... (PRWEB) May 20, 2015 The global ... of 22.3% during the forecast period of 2015 to ... increasingly being used in drug discovery and development process ... market growth. In addition to this,heavy investments by key ... applications are also propelling market growth. Browse 113 market ...
(Date:5/20/2015)... 20, 2015  Cypher Genomics, Inc., a leading ... Celgene Corporation to apply Cypher,s Coral TM ... with patient response to innovative medicines. The information ... accelerate patient access to the right medicine at ... and development and potentially inform new companion diagnostics.  ...
Breaking Biology Technology:Sun Health Foundation Provides $3.25M to Expand, Relocate Banner Del E. Webb Medical Center Pharmacy 2Sun Health Foundation Provides $3.25M to Expand, Relocate Banner Del E. Webb Medical Center Pharmacy 3Veracyte Presents Preliminary Data Demonstrating Ability of Molecular Classifier to Improve Non-Surgical IPF Diagnosis Using Bronchoscopy Samples 2Veracyte Presents Preliminary Data Demonstrating Ability of Molecular Classifier to Improve Non-Surgical IPF Diagnosis Using Bronchoscopy Samples 3Veracyte Presents Preliminary Data Demonstrating Ability of Molecular Classifier to Improve Non-Surgical IPF Diagnosis Using Bronchoscopy Samples 4Veracyte Presents Preliminary Data Demonstrating Ability of Molecular Classifier to Improve Non-Surgical IPF Diagnosis Using Bronchoscopy Samples 5Genotyping Market Growing at 22.3% CAGR to 2020: Research Based on Technology, Applications, Opportunities, Challenges and Key Players. 2Genotyping Market Growing at 22.3% CAGR to 2020: Research Based on Technology, Applications, Opportunities, Challenges and Key Players. 3Genotyping Market Growing at 22.3% CAGR to 2020: Research Based on Technology, Applications, Opportunities, Challenges and Key Players. 4Genotyping Market Growing at 22.3% CAGR to 2020: Research Based on Technology, Applications, Opportunities, Challenges and Key Players. 5Cypher Genomics Collaborates with Celgene Corporation to Identify Novel Genomic Biomarkers 2
... Nile Therapeutics, Inc. (Nasdaq: NLTX ), a company focused ... announced that it has completed the dose escalation stage of an ... heart failure.  Nile had previously announced that the study, NIL-CDNP-CT005, was ... Phase II studies. , , ...
... May 7, 2010 HOYA Corporation today,announced financial results for the fourth ... 104.8 billion yen for the quarter,representing an increase of 26.4% from ... recovery in orders in the main business fields,such as Electro-Optics, as well as ... , ...
... the Swedish medical university Karolinska Institutet shows that the ... cholesterol and thereby cause an inflammation that leads to ... receptors, the researchers have managed to inhibit the development ... in the distinguished periodical Journal of Experimental Medicine ...
Cached Biology Technology:Nile Therapeutics Completes Dose Escalation in Ongoing Phase II Study 2Nile Therapeutics Completes Dose Escalation in Ongoing Phase II Study 3Hoya Announces Fourth Quarter and Full-Year Financial Results 2Hoya Announces Fourth Quarter and Full-Year Financial Results 3New atherosclerosis vaccine gives promising results 2
(Date:5/19/2015)... 19, 2015 Research ... addition of the  "Genetic Testing Market Outlook ... http://photos.prnewswire.com/prnh/20130307/600769) , ,A recent report, Genetic Testing ... of the current and future genetic testing ... their working principles and types are covered ...
(Date:5/14/2015)... , May 14, 2015 Research and Markets ... of the "Fingerprint Sensors Market in Smart Mobile ... This report believes that 2014 was a watershed year ... Apple,s introduction of ,Apple Pay,. Apple gave fingerprint sensors ... mobile payment service. Fingerprint sensors are a must-have feature ...
(Date:5/11/2015)... May 11, 2015  Synaptics Incorporated (NASDAQ: ... solutions, today announced the appointment of Wajid ... Financial Officer, reporting to Rick Bergman , ... Chief Financial Officer, Kathleen Bayless , who ... Mr. Ali brings extensive financial management expertise ...
Breaking Biology News(10 mins):Global Genetic Testing Market Outlook 2018 2Global Smart Mobile Devices Fingerprint Sensors Market 2015-2019: Key Vendors are Authentec, Validity Sensors, Fingerprint Cards, Next Biometrics Group. IDEX, and Qualcomm 2Synaptics Appoints Wajid Ali as Senior Vice President and Chief Financial Officer 2
... Recreation Area,s water quality is good, the sport fish populations ... increasing number of birds. This positive trend is documented in ... understanding of the natural resources of Lake Mead and Lake ... of Lake Mead NRA. "While the Lake Mead ecosystem ...
... , Boulder, Colo., USA - Geology content posted online 4 ... to video observations of erupting geysers in Russia and from ... Highlights and detailed information about each article are listed below. ... of early Earth ,3. Sagaing fault, Indo-Burmese wedge ,4. Anthropogenic ...
... Science Foundation has notified Oregon State University that it will ... design and coordinate the construction of as many as three ... capabilities of the United States. OSU initially will receive ... project and if funds are appropriated for all three ...
Cached Biology News:Lake Mead aquatic-science research documents substantial improvements in ecosystem 2Lake Mead aquatic-science research documents substantial improvements in ecosystem 3GEOLOGY starts 2013 with 25 new articles posted online ahead of print 2GEOLOGY starts 2013 with 25 new articles posted online ahead of print 3GEOLOGY starts 2013 with 25 new articles posted online ahead of print 4GEOLOGY starts 2013 with 25 new articles posted online ahead of print 5GEOLOGY starts 2013 with 25 new articles posted online ahead of print 6GEOLOGY starts 2013 with 25 new articles posted online ahead of print 7GEOLOGY starts 2013 with 25 new articles posted online ahead of print 8GEOLOGY starts 2013 with 25 new articles posted online ahead of print 9GEOLOGY starts 2013 with 25 new articles posted online ahead of print 10GEOLOGY starts 2013 with 25 new articles posted online ahead of print 11GEOLOGY starts 2013 with 25 new articles posted online ahead of print 12GEOLOGY starts 2013 with 25 new articles posted online ahead of print 13GEOLOGY starts 2013 with 25 new articles posted online ahead of print 14GEOLOGY starts 2013 with 25 new articles posted online ahead of print 15GEOLOGY starts 2013 with 25 new articles posted online ahead of print 16GEOLOGY starts 2013 with 25 new articles posted online ahead of print 17GEOLOGY starts 2013 with 25 new articles posted online ahead of print 18GEOLOGY starts 2013 with 25 new articles posted online ahead of print 19GEOLOGY starts 2013 with 25 new articles posted online ahead of print 20GEOLOGY starts 2013 with 25 new articles posted online ahead of print 21NSF selects OSU to lead project rejuvenating US research fleet 2NSF selects OSU to lead project rejuvenating US research fleet 3NSF selects OSU to lead project rejuvenating US research fleet 4
The Synergy HT utilizes a unique dual-optics design combined with monochromator wavelength selection to provide uncompromised performance in absorbance, fluorescence and luminescence reading modes. ...
... SYBR Green I nucleic acid gel ... gel stain that has bright fluorescence when bound ... it ideal for detecting dsDNA in gels using ... I nucleic acid stain has also found uses ...
Synonym: modified Grace's Insect medium...
... ingredient in Molecular Probes. SlowFadeAntifade Kits ... act as a free radical scavenger ... original SlowFade formulation (S-2828) was designed ... fluorescein to almost zero (Figure 1); ...
Biology Products: